- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Their Altman-Z Scores suggest they're not worth buying.
They're in a vulnerable state, according to a gauge known as the Altman Z Score.
Still, performance has suffered recently as investors pile into growth stocks.
The Dividend Stars portfolio underperformed the S&P 500 in February.
The Dividend Stars portfolio underperformed the S&P 500 by 2.25% in January
The Dividend Stars portfolio outperformed the S&P 500 by 0.83% in December
The Chinese real estate market is falling into a funk, so portfolio action is required.
In a shortened month, the Dividend Stars portfolio outperformed the S&P 500 by 1.22%
In an era of low yields, this portfolio offers investors both growth and income.
The deal Web site's IPO is Thursday. With so much hating, what's to love?